ArticleKidney medicine2026
Association Between Time Spent With Low Posttransplant Glomerular Filtration Rate and Access to Relisting and Retransplantation.
Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rationale & Objective: For transplant recipients with low estimated glomerular filtration rate (eGFR), early preparation is needed to optimize the transition back to dialysis or retransplantation. Our objective was to determine if the amount of time spent with low eGFR was associated with a higher likelihood of relisting or retransplantation within 1 year of graft failure. Study Design: Retrospective cohort study. Setting & Participants: We included adults who developed graft failure between 2010 and 2021 according to the US Renal Data System. Exposure: We modeled the time spent with eGFR between 20 and 5 mL/min/1.73 m Outcome: Relisting or retransplantation within 1 year of graft failure. Analytical Approach: We used Fine-Gray models accounting for the competing risk of death to determine the association between time spent with low eGFR (as a categorical variable) and outcomes of interest. Results: We included 14,680 patients; median age at graft failure was 53 years (IQR, 42-61). Within 1 year of graft failure, ∼18% (n = 2,690) of patients were relisted and 13% (n = 1,854) were retransplanted. In adjusted models, spending 2-4 years (SHR, 1.43; 95% confidence interval [CI], 1.16-1.75) or >4 years (SHR, 1.28; 95% CI, 1.04-1.57) with low eGFR was associated with a higher likelihood of relisting (vs spending <2 years with low eGFR). Similarly, spending 2-4 years (SHR, 1.37; 95% CI, 1.09-1.72) or >4 years (SHR, 1.73; 95% CI, 1.37-2.19) with low eGFR was also associated with a higher likelihood of retransplantation within 1 year of graft failure. Limitations: Residual confounding; observational nature of study. Conclusions: Timely preparation of patients with low eGFR for retransplantation could increase patients' likelihood of early relisting and retransplantation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.